Delcath Systems Stock

Delcath Systems Current Ratio

The Current Ratio of Delcath Systems (DCTH) as of Aug 4, 2026 is 9.73. In the previous year, Current Ratio was 6.51 — a change of 49.49% (higher).

Current Ratio

9.73

YoY

49.49%

Last updated:

Current Ratio of Delcath Systems is 2026 9.73 . Current Ratio of Delcath Systems was 2025 6.51 . It decreases by 49.49% higher compared to the previous year.
Access this data via the Eulerpool API

Delcath Systems Stock analysis

What does Delcath Systems do? Delcath Systems Inc is a US-American medical technology company specializing in the development of innovative products for the treatment of various forms of liver cancer. The company was founded in 1988 in New York and is headquartered in Queensbury today. Delcath Systems is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Delcath Systems stock

Current Ratio of Delcath Systems is 9.73 in 2026.

Current Ratio of Delcath Systems changed from 6.51 to 9.73, representing a 49.49% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Ratio Delcath Systems since 2006 – with annual values, charts, and detailed analysis.

The Current Ratio measures a company's ability to pay short-term obligations. A ratio above 1 indicates that current assets exceed current liabilities.

Current Ratio = Current Assets / Current Liabilities

A 'good' varies by industry and company stage. On Eulerpool, you can compare Current Ratio's Delcath Systems with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — Delcath Systems

All Key Metrics — Delcath Systems